US Initiative To End HIV Epidemic Will Boost PrEP Access

'Number of different initiatives' coming in next several months to make drugs more affordable, including for PrEP prophylaxis, HHS Assistant Secretary for Health Giroir says. Multi-agency approach is key strategy.

PS1902_NO-HIV_349342427_1200.jpg

More individuals will gain access to HIV drugs and pre-exposure prophylaxis (PrEP) medication under the the Trump administration's new multi-agency Initiative to End the HIV Epidemic, via strategies such as increasing affordability of PrEP obtained through federally qualified community health centers.

HHS officials provided some specifics on the plan Feb. 6, following its unveiling in the president's State of the Union...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access